I+D de fármacos
GI-1606
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (1)
2022
-
Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
Journal of the American Chemical Society, Vol. 144, Núm. 12, pp. 5284-5294